SCHEMBL26219729

SCHEMBL26219729

CC(C)(C)c1ccc(Nc2cccc(Cl)c2)c(-c2ccccc2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FADS1 O60427 2/20 0.44
ABCG2 Q9UNQ0 3/20 0.43
ABCB1 P08183 1/20 0.43
ABCC1 P33527 1/20 0.43
KCNK18 Q7Z418 1/20 0.43
HPGD P15428 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
AKR1C3 P42330 2/20 0.42
AKR1C2 P52895 2/20 0.42
MEN1 O00255 1/20 0.42
LMNA P02545 1/20 0.42
GFER P55789 1/20 0.42
KMT2A Q03164 1/20 0.42
GSK3B P49841 1/20 0.42
MPO P05164 1/20 0.41
ACP1 P24666 2/20 0.41
PDE5A O76074 3/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30496501 1.00 FADS1 (0.44) FADS1ABCG2ABCB1ABCC1KCNK18
SCHEMBL22938850 0.89 KCNK18 (0.52) ABCG2KCNK18SMN1; SMN2AKR1C3AKR1C2
SCHEMBL30526474 0.89 KCNK18 (0.52) ABCG2KCNK18SMN1; SMN2AKR1C3AKR1C2
SCHEMBL25120147 0.87 ALDH1A1 (0.44) ABCG2KCNK18HPGDSMN1; SMN2AKR1C3
SCHEMBL30561839 0.87 ALDH1A1 (0.44) ABCG2KCNK18HPGDSMN1; SMN2AKR1C3
SCHEMBL22258466 0.85 KCNK18 (0.49) ABCG2KCNK18SMN1; SMN2AKR1C3AKR1C2
SCHEMBL24174921 0.85 NPSR1 (0.50) ABCG2ABCB1KCNK18HPGDSMN1; SMN2
SCHEMBL22432174 0.84 KCNK18 (0.48) ABCG2KCNK18SMN1; SMN2MPOALDH1A1
SCHEMBL22432185 0.84 KCNK18 (0.48) ABCG2KCNK18SMN1; SMN2MPOALDH1A1
SCHEMBL30679843 0.84 KCNK18 (0.48) ABCG2KCNK18SMN1; SMN2MPOALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117700435-A Light emitting device and condensed polycyclic compound for light emitting device 三星显示有限公司 2024-03-15 CN disclosed
CN-112236434-B Polycyclic compound and organic light emitting device including the same 株式会社LG化学 2024-02-23 CN disclosed
US-20230403934-A1 LIGHT EMITTING ELEMENT AND POLYCYCLIC COMPOUND FOR THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-12-14 US disclosed
CN-117209518-A Light emitting element and polycyclic compound for use therein 三星显示有限公司 2023-12-12 CN disclosed
US-20230329109-A1 POLYCYCLIC AROMATIC DERIVATIVE COMPOUND AND ORGANOELECTROLUMINESCENT DEVICE USING SAME SFC CO., LTD. (KR) 2023-10-12 US disclosed
CN-113841264-B Organic light-emitting element 株式会社LG化学 2023-08-15 CN disclosed
CN-116574116-A Condensed cyclic compound, light-emitting device including the same, and electronic device 三星显示有限公司 2023-08-11 CN disclosed
US-20230255100-A1 CONDENSED CYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-08-10 US disclosed
US-20230255100-A1 CONDENSED CYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-08-10 US disclosed
US-20230127929-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-04-27 US disclosed
US-20230127929-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230403934-A1 LIGHT EMITTING ELEMENT AND POLYCYCLIC COMPOUND FOR THE SAME NFE2L2, ESR1, ELP1 FADS1 3818/4885ABCG2 4605/4885ABCB1 4378/4885
US-20230255100-A1 CONDENSED CYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE CRY1, CCNE2, NCAPH FADS1 3503/4885ABCG2 4645/4885ABCB1 4377/4885
US-20230329109-A1 POLYCYCLIC AROMATIC DERIVATIVE COMPOUND AND ORGANOELECTROLUMINESCENT DEVICE USING SAME DDT, UROD, DDC FADS1 2195/4885ABCG2 1334/4885ABCB1 3318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.